Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Current marketed FLOLAN (epoprostenol sodium)[1] Epoprostenol (Synonym: Flolan)[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
2Flolan[1] Epoprostenol (Synonym: Flolan)[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
3FLOLAN injection with currently marketed diluent[1] Epoprostenol (Synonym: Flolan)[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
4FLOLAN injection with reformulated diluent[1] Epoprostenol (Synonym: Flolan)[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
5FLOLAN TM and Glycine Diluent[2] Epoprostenol (Synonym: Flolan),
Glycine (Synonym: Sterile Diluent for Flolan Injection)		[2] D00011 ,
D00106 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
6Flolan®[1] Epoprostenol (Synonym: Flolan)[1] D00106 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
7FLOLAN™ and Glycine Diluent[2] Epoprostenol (Synonym: Flolan),
Glycine (Synonym: Sterile Diluent for Flolan Injection)		[2] D00011 ,
D00106 		[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86